TargetMol

RE 1492

Product Code:
 
TAR-T26052
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26052-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26052-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26052-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
RE 1492 is an oligoamine that gives it an antiplatelet effect when combined with antithrombic drugs.
CAS:
112169-14-9
Formula:
C39H51N3
Molecular Weight:
561.858
Purity:
0.98
SMILES:
C(CCc1ccccc1)CNCc1cc(CNCCCCc2ccccc2)cc(CNCCCCc2ccccc2)c1

References

1. Rehse K, Ciborski T. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVI: Antiplatelet and antithrombotic effects of the oligoamine RE 1492 in combination with standard and future antithrombotic drugs. Arch Pharm (Weinheim). 1995 Apr;328(4):333-7. PubMed PMID: 7611829. 2. Kesselhut A, Ebel H, von Bruchhausen F, Rehse K. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXV: Interactions of the oligoamine RE 1492 with biomembranes. Arch Pharm (Weinheim). 1995 Jan;328(1):21-7. PubMed PMID: 7695469. 3. Rehse K, M?ller S. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIX: Influence of the antithrombotic oligoamine RE 1492 on the storage of red blood cells, morphology, their potassium and ATP content, hemolysis and viability. Arch Pharm (Weinheim). 1995 Apr;328(4):339-42. PubMed PMID: 7611830. 4. Neumann M, M?ller S, Grosse J, Lerche D, Rehse K. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIII: Influence of the oligoamine RE 1492 on the deformability of red blood cells. Arch Pharm (Weinheim). 1994 Aug;327(8):497-501. PubMed PMID: 7944905.